Phase 3 Study to Treat Patients With Soft Tissue Sarcomas
Phase 3 Completed
433 enrolled 10 charts
A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma
Phase 2 Completed
22 enrolled 13 charts
GemTax
Phase 1/2 Completed
37 enrolled 17 charts
SOURCE
Phase 2 Completed
209 enrolled 18 charts
Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas
Phase 1 Completed
47 enrolled
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer
Phase 1 Completed
18 enrolled
Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma
Phase 2 Completed
90 enrolled
Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue Sarcoma
Phase 1/2 Completed
6 enrolled
Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes
Phase 2 Completed
47 enrolled 7 charts
Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma
Phase 2 Completed
84 enrolled 7 charts
Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma
Phase 1 Completed
38 enrolled
Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma
Phase 2 Completed
STS
Phase 2 Completed
58 enrolled
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
Phase 2 Completed
82 enrolled
Docetaxel in Treating Children With Recurrent Solid Tumors
Phase 2 Completed
20 enrolled
Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
Phase 2 Completed
54 enrolled 8 charts
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Phase 1 Completed
26 enrolled
Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma
Phase 3 Completed
120 enrolled